Dr Martin Altschwager > Baker McKenzie > Frankfurt, Germany > Lawyer Profile

Baker McKenzie
Junghofstrasse 9
60315 FRANKFURT AM MAIN
Germany
Martin Altschwager photo

Work Department

Life Sciences

Position

Dr. Martin Altschwager, a Partner, is a member of Baker McKenzie’s Pharmaceuticals and Healthcare Practice Group in Frankfurt. Prior to joining the Firm in May 2013, he worked in the pharmaceuticals and healthcare group of a major German law firm in Stuttgart. Dr. Altschwager has completed a comparative PhD thesis on European and US drug law as well as co-authored a publication on the reimbursement of medicinal products.

Dr. Altschwager advises national and international clients on all aspects of European and German pharmaceutical and medical device law as well as on compliance and unfair competition issues pertaining to healthcare products and services. In particular, Martin provides legal advice on regulatory issues regarding the market access, manufacturing, distribution and advertising of medicinal products and medical devices. He also regularly assists clients in negotiating and drafting agreements with research and development facilities, manufacturers and distributors.

Languages

English, French, German, Spanish

Education

  • Philipps University Marburg (Dr. iur.) (2015)
  • University of Virginia School of Law (LL.M.) (2011)
  • State of Baden-Württemberg (Assessor Exam) (2009)
  • University of Mannheim (Referendar Exam) (2007)

Lawyer Rankings

Deutschland > Branchenfokus > Gesundheit

(Partner der nächsten Generation)

Martin Altschwager – Baker McKenzie

Baker McKenzie’s facettenreiches Beratungsangebot beinhaltet eine starke Transaktionspraxis, kombiniert mit regulatorischem Fachwissen, welches auch im Rahmen von Arzneimittelhaftungsfragen und der Beratung zu Digitalen Gesundheitsanwendungen (DiGA) Einsatz findet, und Erfahrung im Heilmittelwerberecht. Die kartellrechtliche Expertise des Teams wird von Mandanten unter anderem im Zusammenhang mit der Entwicklung neuartiger Arzneimittel in Anspruch genommen. Praxisgruppenleiter Thilo Räpple verfügt über jahrelange Erfahrung in der Arzneimittel- und Medizinprodukteindustrie und unterstützt regelmäßig M&A-Transaktionen mit regulatorischem Fachwissen, welches gleichzeitig auch in der Beratung zu Vereinbarungen hinsichtlich Entwicklung, Einführung und Vermarktung von Medizinprodukten zur Anwendung kommt. Martin Altschwager ist ein weiterer wichtiger Ansprechpartner für regulatorische Fragestellungen und war zuletzt mit der Beratung zu Vertriebsstrukturen und Zulassungspflichten befasst.

Germany > Industry focus > Healthcare and life sciences

(Next Generation Partners)

Martin Altschwager – Baker McKenzie

Baker McKenzie diverse advisory offering includes longstanding transaction support, regulatory expertise, which is regularly drawn on in connection with product liability issues in the pharmaceutical sector, the advice on digital healthcare apps as well as pharmaceutical advertising law. The team’s antitrust expertise is regularly requested by clients in connection with the development of novel drugs. Practice head Thilo Räpple is well versed in the pharmaceutical and medical device industry and regularly supports transactions, including regulatory aspects, and also advises on contract-related matters pertaining to the development, launch and marketing of medical devices. Martin Altschwager is a key contact for regulatory issues and most recently assisted with distribution systems and approval requirements.